C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors
dc.contributor.author | Ioannidis, P. | en |
dc.contributor.author | Trangas, T. | en |
dc.contributor.author | Dimitriadis, E. | en |
dc.contributor.author | Samiotaki, M. | en |
dc.contributor.author | Kyriazoglou, I. | en |
dc.contributor.author | Tsiapalis, C. M. | en |
dc.contributor.author | Kittas, C. | en |
dc.contributor.author | Agnantis, N. | en |
dc.contributor.author | Nielsen, F. C. | en |
dc.contributor.author | Nielsen, J. | en |
dc.contributor.author | Christiansen, J. | en |
dc.contributor.author | Pandis, N. | en |
dc.date.accessioned | 2015-11-24T16:32:34Z | |
dc.date.available | 2015-11-24T16:32:34Z | |
dc.identifier.issn | 0020-7136 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/7565 | |
dc.rights | Default Licence | - |
dc.subject | Amino Acid Motifs | en |
dc.subject | Animals | en |
dc.subject | Base Sequence | en |
dc.subject | Cell Division | en |
dc.subject | Chromosome Mapping | en |
dc.subject | DNA, Complementary/metabolism | en |
dc.subject | Humans | en |
dc.subject | Mesenchymoma/*metabolism | en |
dc.subject | Mice | en |
dc.subject | Molecular Sequence Data | en |
dc.subject | Protein Binding | en |
dc.subject | Proto-Oncogene Proteins c-myc/metabolism | en |
dc.subject | RNA/metabolism | en |
dc.subject | RNA, | en |
dc.title | C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors | en |
heal.abstract | Mouse coding region determinant-binding (mCRD-BP) and human IGF-II mRNA-binding 1 (hIMP-1) proteins are orthologous mRNA-binding proteins that recognize c-myc and IGF-II mRNA, respectively, and regulate their expression posttranscriptionally. Here, we confirm that human CRD-BP/IMP-1 binds to c-myc mRNA and that it is predominantly expressed in fetal tissues. Moreover, hCRD-BP/IMP-1 expression was detected in cell lines of neoplastic origin and in selected primary tumors. In a series of 33 malignant and 10 benign mesenchymal tumors, 73% and 40%, respectively, were found to express hCRD-BP/IMP-1. In particular, expression was significant in 14 Ewing's sarcomas, all of which were positive. The data suggest that hCRD-BP/IMP-1 plays a role in abnormal cell proliferation in mesenchymal tumors. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11745432 | - |
heal.journalName | Int J Cancer | en |
heal.journalType | peer reviewed | - |
heal.language | en | - |
heal.publicationDate | 2001 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιών | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: